Skip to main content

Table 5 Univariate analysis of risk factors for CMV IgM positive in patients with inflammatory bowel disease

From: The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China

 

CMV IgM+/IgM-

 

UC

CD

 

(3/186)

(1/36)

Age

Number

P value

OR (95% CI)

Number

P value

OR (95% CI)

 ≤50 ys

2/137

1.000

0.715 (0.063 ~ 8.065)

1/23

1.000

N/A

 >50 ys

1/49

  

0/13

  

Sex

      

 male

2/107

1.000

1.477 (0.132 ~ 16.573)

1/22

1.000

N/A

 female

1/79

  

0/14

  

Smoking

      

 yes

1/44

1.000

1.614 (0.143 ~ 18.222)

1/8

0.243

N/A

 no

2/142

  

0/28

  

Drinking

      

 yes

1/74

1.000

0.757 (0.067 ~ 8.496)

0/12

1.000

N/A

 no

2/112

  

1/24

  

Diet composition

      

 vegetarian food

0/18

1.000

N/A

0/6

1.000

N/A

 mixed food

3/168

  

1/30

  

Fever

      

 yes

1/31

1.000

2.500 (0.220 ~ 28.432)

0/4

1.000

N/A

 no

2/155

  

1/32

  

Hemoglobin (G/L)

      

 ≤70

1/8

0.329

11.125 (0.911 ~ 135.909)

0/0

-

N/A

 >70

2/178

  

1/36

  

Albumin (G/L)

      

 ≤35

2/19

0.031*

17.579 (1.522 ~ 203.083)

1/12

0.351

N/A

 >35

1/167

  

0/24

  

Disease severity

      

 mild and moderate

1/167

0.031*

0.057 (0.005 ~ 0.657)

1/29

1.000

N/A

 severe

2/19

  

0/7

  

Location

      

 distal colitis

1/139

0.337

0.169 (0.015 ~ 1.907)

   

 pancolitis

2/47

     

 ileal

   

1/7

0.155

N/A

 Colonic

   

0/14

  

 ileocolon

   

0/15

  

Treatment

      

ASA/SASP

3/146

1.000

N/A

1/19

1.000

N/A

corticosteroids

3/44

0.015*

N/A

0/8

1.000

N/A

immunosuppressant

3/2

<0.001*

N/A

0/2

1.000

N/A

  1. CMV, cytomegalovirus; UC, ulcerative colitis; CD, Crohn’s disease; OR, Odds ratio; CI, confidence interval; ASA, aminosalicylic acid; SASP, salicylazosulfapyridine.
  2. *indicate significant difference.